Successful treatment of a hypothalamic lesion in neuromyelitis optica by plasma exchange [3]

Journal of Neurology

Volumn 254, Issue 5, 2007, Pages 670-671

  Watanabe, Shohei ^a   Nakashima, Ichiro ^a   Miyazawa, Isabelle ^a   Misu, Tatsuro ^a   Shiga, Yusei ^a   Nakagawa, Yoichi ^a   Fujihara, Kazuo ^a   Itoyama, Yasuto ^a  

^a TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Hypothalamic lesion; Neuromyelitis optica; Plasma exchange; Therapy

Indexed keywords

ALBUMIN; ANTINUCLEAR ANTIBODY; GADOLINIUM; IMMUNOGLOBULIN G; METHYLPREDNISOLONE; PROLACTIN;

ADULT; BLINDNESS; CASE REPORT; CERVICAL SPINAL CORD; CLINICAL EFFECTIVENESS; CONTRAST ENHANCEMENT; DRUG MEGADOSE; DRUG TREATMENT FAILURE; FEMALE; HUMAN; HYPERPROLACTINEMIA; HYPOTHALAMUS LESION; LETTER; MEDULLA OBLONGATA; MYELITIS; MYELOOPTIC NEUROPATHY; NEUROPATHOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; OPTIC NEURITIS; PLASMAPHERESIS; PRIORITY JOURNAL; PROLACTIN BLOOD LEVEL; RELAPSE; SPINAL CORD LESION; TREATMENT RESPONSE; VISUAL FIELD DEFECT;

ADULT; FEMALE; HUMANS; HYPOTHALAMUS; NEUROMYELITIS OPTICA; PLASMA EXCHANGE;

EID: 34249103883     PISSN: 03405354     EISSN: 14321459     Source Type: Journal    
DOI: 10.1007/s00415-006-0329-2     Document Type: Letter

References (9)

1. Cree BAC, Lamb S, Morgan K, Chen A, Waubant E, Genain C (2005) An open label study of the effects of rituximab in neuromyelitis optica. Neurology 64:1270-1272
2. Keegan M, Pineda AA, McClelland RL, Darby CH, Rodriguez M, Weinshenker BG (2002) Plasma exchange for severe attacks of CNS demyelination: Predictors of response. Neurology 58:143-146
3. Lennon VA, Wingerchuk DM, Kryzer TJ, Pittock SJ, Lucchinetti CF, Fujihara K, Nakashima I, Weinshenker BG (2004) A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet 364:2106-2112
4. Lucchinetti CF, Mandler RN, McGavern D, Bruck W, Gleich G, Ransohoff RM, Trebst C, Weinshenker B, Wingerchuk D, Parisi JE, Lassmann H (2002) A role for humoral mechanisms in the pathogenesis of Devic's neuromyelitis optica. Brain 125:1450-1461
5. Poppe AY, Lapierre Y, Melancon D, Lowden D, Wardell L, Fullerton LM, Bar-Or A (2005) Neuromyelitis optica with hypothalamic involvement. Mult Sclr 11:617-621
6. Ruprecht K, Klinker E, Dintelmann, Rieckmann P, Gold R (2004) Plasma exchange for severe optic neuritis: treatment of 10 patients. Neurology 63:1081-1083
7. Tommasi M, Lecuire J, Masquin A, Buffat JJ (1966) Etude anatomo-clinique d'une neuromyèlite optique de Devic, d'èvolution artificiellement prolongèe. Encèphalite septique terminale. Rev Neurol (Paris) 114:378-381
8. Vernant JC, Cabre P, Smadja D, Merle H, Caubarrere I, Mikol J, Poser CM (1997) Recurrent optic neuromyelitis with endocrinopathies: A new syndrome. Neurology 48:58-64
9. Weinshenker BG, O'Brien PC, Petterson TM, Noseworthy JH, Lucchinetti CF, Dodick DW, Pineda AA, Stevens LN, Rodriguez M (1999) A randomized trial of plasma exchange in acute central nervous system inflammatory demyelinating disease. Ann Neurol 46:878-886